rs6768943
Positions:
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_StrongBP6_ModerateBP7BA1
The NM_001366028.2(DNAH12):c.4338C>T(p.Tyr1446=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.515 in 1,550,476 control chromosomes in the GnomAD database, including 210,621 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.45 ( 16936 hom., cov: 32)
Exomes 𝑓: 0.52 ( 193685 hom. )
Consequence
DNAH12
NM_001366028.2 synonymous
NM_001366028.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.378
Genes affected
DNAH12 (HGNC:2943): (dynein axonemal heavy chain 12) Predicted to enable several functions, including ATP binding activity; dynein intermediate chain binding activity; and dynein light intermediate chain binding activity. Predicted to be involved in microtubule-based movement. Predicted to be located in cilium; cytoplasm; and microtubule. Predicted to be part of dynein complex. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
BP4
?
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
?
Variant 3-57445261-G-A is Benign according to our data. Variant chr3-57445261-G-A is described in ClinVar as [Benign]. Clinvar id is 402637.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
?
Synonymous conserved (PhyloP=0.378 with no splicing effect.
BA1
?
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.574 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
DNAH12 | NM_001366028.2 | c.4338C>T | p.Tyr1446= | synonymous_variant | 28/74 | ENST00000495027.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
DNAH12 | ENST00000495027.6 | c.4338C>T | p.Tyr1446= | synonymous_variant | 28/74 | 5 | NM_001366028.2 | P1 | |
DNAH12 | ENST00000351747.6 | c.4269C>T | p.Tyr1423= | synonymous_variant | 28/59 | 5 |
Frequencies
GnomAD3 genomes ? AF: 0.446 AC: 67692AN: 151898Hom.: 16938 Cov.: 32
GnomAD3 genomes
?
AF:
AC:
67692
AN:
151898
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.522 AC: 81365AN: 155998Hom.: 22159 AF XY: 0.531 AC XY: 43875AN XY: 82686
GnomAD3 exomes
AF:
AC:
81365
AN:
155998
Hom.:
AF XY:
AC XY:
43875
AN XY:
82686
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.522 AC: 730033AN: 1398460Hom.: 193685 Cov.: 47 AF XY: 0.526 AC XY: 362467AN XY: 689642
GnomAD4 exome
AF:
AC:
730033
AN:
1398460
Hom.:
Cov.:
47
AF XY:
AC XY:
362467
AN XY:
689642
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.445 AC: 67694AN: 152016Hom.: 16936 Cov.: 32 AF XY: 0.453 AC XY: 33642AN XY: 74276
GnomAD4 genome
?
AF:
AC:
67694
AN:
152016
Hom.:
Cov.:
32
AF XY:
AC XY:
33642
AN XY:
74276
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1819
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at